Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Craven

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Hospital Formulary|January 1, 1993
Treating bone and joint infections with teicoplanin: hospitalization vs outpatient cost issuesP C Craven
Drugs|January 1, 1983
Antifungal agents used in systemic mycoses. Activity and therapeutic useJ R Graybill, P C Craven
Antimicrobial Agents and Chemotherapy|May 1, 1985
Risk factors of ventricular fibrillation during rapid amphotericin B infusionP C Craven, D H Gremillion
The Journal of Infectious Diseases|April 1, 1984
Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitisP C Craven, J R Graybill
The American Review of Respiratory Disease|June 1, 1982
Ketoconazole therapy of murine cryptococcal meningitisP C Craven, J R Graybill, J H Jorgensen
Sabouraudia|January 1, 1984
Treatment of experimental murine candidiasis with liposome-associated amphotericin BJ Ahrens, J R Graybill, P C Craven, et al.
The American Review of Respiratory Disease|July 1, 1982
Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimensJ R Graybill, P C Craven, W Donovan, et al.
Archives of Internal Medicine|March 1, 1984
Typhoid fever. An epidemic with remarkably few clinical signs and symptomsS A Klotz, J H Jorgensen, F J Buckwold, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1978
Interaction of chemotherapy and immune defenses in experimental murine cryptococcosisJ R Graybill, P C Craven, L F Mitchell, et al.
The American Journal of Medicine|June 1, 1977
Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapyP C Craven, J H Jorgensen, R L Kaspar, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Hospital Formulary|January 1, 1993
Treating bone and joint infections with teicoplanin: hospitalization vs outpatient cost issuesP C Craven
Drugs|January 1, 1983
Antifungal agents used in systemic mycoses. Activity and therapeutic useJ R Graybill, P C Craven
Antimicrobial Agents and Chemotherapy|May 1, 1985
Risk factors of ventricular fibrillation during rapid amphotericin B infusionP C Craven, D H Gremillion
The Journal of Infectious Diseases|April 1, 1984
Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitisP C Craven, J R Graybill
The American Review of Respiratory Disease|June 1, 1982
Ketoconazole therapy of murine cryptococcal meningitisP C Craven, J R Graybill, J H Jorgensen
Sabouraudia|January 1, 1984
Treatment of experimental murine candidiasis with liposome-associated amphotericin BJ Ahrens, J R Graybill, P C Craven, et al.
The American Review of Respiratory Disease|July 1, 1982
Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimensJ R Graybill, P C Craven, W Donovan, et al.
Archives of Internal Medicine|March 1, 1984
Typhoid fever. An epidemic with remarkably few clinical signs and symptomsS A Klotz, J H Jorgensen, F J Buckwold, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1978
Interaction of chemotherapy and immune defenses in experimental murine cryptococcosisJ R Graybill, P C Craven, L F Mitchell, et al.
The American Journal of Medicine|June 1, 1977
Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapyP C Craven, J H Jorgensen, R L Kaspar, et al.
Pageof 3